ASYA BRAGINSKY: Open Payments
NPI 1568488948 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 22 payments from 13 companies in 2025. Trend: 2023 $911 · 2024 $1,129 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $228 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Novo Nordisk Inc | 3 | $92 |
| HEARTFLOW, INC. | 3 | $63 |
| Amgen Inc. | 3 | $43 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: ZENPEP, AMVUTTRA, SYMPLICITY G3, COREVALVE EVOLUT R, Wegovy, FFRct, REPATHA, VERQUVO.
Industry payments across PA — which companies pay providers there.
